What are the open and close dates of the Gujarat Kidney & Super Speciality IPO ?

Gujarat Kidney & Super Speciality IPO will be open between 2025-12-22 and 2025-12-24.

What is the allotment date for the Gujarat Kidney & Super Speciality IPO ?

Gujarat Kidney & Super Speciality IPO allotment date is 2025-12-29. For Gujarat Kidney & Super Speciality IPO allotment status check, you can visit the website of the registrar of the IPO.

Who is the registrar of Gujarat Kidney & Super Speciality IPO ?

For Gujarat Kidney & Super Speciality IPO, the IPO registrar is MUFG Intime India Private Limited. You can check Gujarat Kidney & Super Speciality IPO allotment status on the website of the registrar.

Where is the Gujarat Kidney & Super Speciality IPO getting listed?

The shares are proposed to be listed on the BSE and NSE.

When will Gujarat Kidney & Super Speciality IPO shares be credited to your demat account?

The Gujarat Kidney & Super Speciality IPO shares will typically be credited to your demat account one working day before the IPO's listing date, provided your application is successfully allotted.

What is the lot size and minimum order quantity of the Gujarat Kidney & Super Speciality IPO ?

The Gujarat Kidney & Super Speciality IPO lot size is 128 and minimum order quantity is 128.

What is the price band for the Gujarat Kidney & Super Speciality IPO ?

Gujarat Kidney & Super Speciality IPO has set the price band for its IPO at 114 per equity share with a face value of 2.

Home
/
IPO

4.62x

subscribed

Gujarat Kidney & Super Speciality IPO

Hospital & Healthcare Services

listed

₹13,824Min. investment

Pre-apply
19 Dec
Bid start
22 Dec
Bid end
24 Dec
Allotment
26 Dec
Release of funds
29 Dec
Demat transfer
29 Dec
Listing
30 Dec

Gujarat Kidney & Super Speciality Limited IPO Details

Issue size

₹251Cr

IPO type

Mainboard

Market Cap

₹898.81CrLower than sector avg

Price range

₹108 – ₹114

Listing ExchangeBSE, NSE

RevenueApr 2024 - Mar 2025

₹40.24CrLower than sector avg

Lot size

128 shares

Draft Red Herring Prospectus

Read

Growth rate3Y CAGR

190%

SectorHospital & Healthcare Services

Price range₹108 – ₹114

IPO type

Regular

Lot size128 shares

Issue size₹251Cr

Draft Red Herring Prospectus

Read

Market Cap

₹898.81CrLower than sector avg

RevenueApr 2024 - Mar 2025

₹40.24CrLower than sector avg

Growth rate3Y CAGR

190%

Gujarat Kidney & Super Speciality Limited IPO Overview

Gujarat Kidney and Super Speciality Limited IPO date

Gujarat Kidney and Super Speciality Limited IPO will open for subscription on December 22, 2025, and the closing date for the IPO is December 24, 2025. After this, investors are expected to be updated about the allotment status on December 26, 2025.

Investors who have been allotted shares can expect them to be credited to their demat account on December 29, 2025. The shares will be listed on the NSE and the BSE on Tuesday, December 30, 2025.

Gujarat Kidney and Super Speciality Limited IPO price band

The IPO includes a fresh issue only. The IPO price band has been set between ₹108 to ₹114 per share. Interested investors can choose a price within this band to apply for the IPO.

The IPO is a book-building issue, comprising a fresh issue of ₹250.80 crore. Gujarat Kidney and Super Speciality Limited IPO listing price will be determined on December 30, 2025. The listing price is the price at which a company’s shares debut on the stock exchanges.

Gujarat Kidney and Super Speciality Limited IPO lot size

Gujarat Kidney and Super Speciality Limited IPO details have been declared. The minimum lot size for an application is 128 shares, and the investor would have to apply for a minimum of 1 lot. Meanwhile, the IPO issue size is approximately ₹250.80 crore.

Checklist

Quality analysis

Revenue growth

Company valuation

Earnings expansion

Risk analysis

Debt to Equity ratio

Promoter holdings

Shares pledged

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Compare

Companies in this sector

Apollo Hospitals Enterprise Ltd

Max Healthcare Institute Ltd

Fortis Healthcare Ltd

Revenue

Higher revenue means strong sales and good market demand

This IPO

₹40.24Cr

This sector

₹810.55Cr

Compare with companies

PAT

Higher PAT means strong profitability and efficient cost management

This IPO

₹9.49Cr

This sector

₹87.66Cr

Compare with companies

Market cap

Higher market cap means strong confidence but may suggest overvaluation

This IPO

₹898.81Cr

This sector

₹10,075.9Cr

Compare with companies

P/E ratio

Lower ratio usually means stock is undervalued

This IPO

61.62

This sector

55.14

Compare with companies

D/E ratio

Lower ratio usually means fewer liabilities

This IPO

0.15

This sector

0.40

Compare with companies

Objectives

Funding for acquisition

30.70%

Capital expenditure

14.72%

Part-payment for acquisition

4.94%

Investment in subsidiary

4.30%

Repayment of borrowings

0.48%

Strength and Weakness

Regional leadership in renal and urology

The company has built up a significant healthcare presence in the central part of Gujarat in the field of renal sciences and urology. It has covered the field of urology with various sub-specialities like endourology, urologic oncology, the renal transplant program, and many more right from the start. Altogether, from FY23-FY25 & Q1FY26 onward, more than 2,700 endourology and more than 200 laparoscopic urology procedures have been done.

Asset-light expansion model

The company follows an asset-light business model where it gets control or majority ownership of hospitals without investing heavily in the purchase of land and basic infrastructure for the hospitals. The hospitals in Bharuch, Borsad, Vadodara, Anand, and Godhra are running this way, thus improving return metrics and becoming scalable.

Healthy operating metrics

On March 31, 2025, the average number of beds available for use was 389, with an occupancy level of approximately 56%, which indicates that there is still room for further expansion. The revenue per occupied bed has gone up consistently to ₹10,255 in FY25 from ₹9,305 in FY23, which is a positive sign of more advanced procedures being performed. The length of stay is still 6 days, which helps to keep the throughput and operational planning predictable.

Ability to attract and retain medical talent

The company is very successful in attracting talent and keeping them as employees, and thus it has a very low turnover rate. The turnover of full-time doctors in FY25 and Q1 FY26 was between 2.40% and 2.99%, while the turnover rate of visiting doctors and nurses was close to zero. As of June 30, 2025, the company has 89 doctors and over 330 nurses, who were supported by well-organised engagement models and continuous medical education programs.

Direct patient-led revenue mix

The main source of revenue is the demand for services by patients. A huge 94.54% in Q1FY26 and 90% in FY25 were from individual patients with insurance and walk-ins. Besides that, participation in Ayushman Bharat and corporate empanelments offers additional volumes without compromising price ‍ discipline.

About Gujarat Kidney & Super Speciality Limited

Gujarat Kidney & Super Speciality Limited (GKSL) is a regional healthcare company operating a chain of mid-sized multispeciality hospitals in central Gujarat. The company operates a network of seven multispecialty hospitals & four in-hospital pharmacies with a total of 490 beds under their control, with 445 approved & 340 operational beds as of 30th June 2025. Their hospitals cater to an under-penetrated medical market in Vadodara, Godhra, Bharuch, Borsad, & Anand with demand for affordable & quality healthcare.

GKSL has built a strong clinical franchise in renal sciences, anchored by urology and nephrology. The urology department alone has developed 6 sub-specialities, including endourology, urologic oncology, paediatric urology, reconstructive urology, renal transplant and laparoscopic urology. Healthcare services are broadly classified into secondary care (surgical services) and tertiary care (super-speciality surgical services), supported by in-house diagnostics and pharmacy operations within hospital premises. Between FY23 and Q1FY26, the company performed over 2,700 endourology procedures and more than 200 laparoscopic urology procedures. Its Vadodara facility is authorised to perform renal transplants and has completed 31 transplants till the RHP date.

The healthcare network pursues an asset-light model of expansion, with several hospitals under lease agreements or majority equity acquisitions, which do not require significant capital investments. GKSL has controlling stakes of 51% to 90% in a number of hospitals, including those in Bharuch, Borsad, and Vadodara, which enable them to operate without actually owning the lands and properties. The company is in the middle of another acquisition – Parekhs Hospital in Ahmedabad, which currently operates 49 beds.

Patient revenue is largely driven by direct demand. In FY25, it stood at 90% for self-pay and individually insured patients, which rose to an impressive 94.54% in Q1FY26, with minimal reliance on institutional and government payers, showing a strong recall at a regional level. Although it operates under Ayushman schemes and other insurance programs, such agreements are meant to be volume boosters rather than revenue generators.

As of November 2025, GKSL had approximately 670 employees, including 89 full-time consultants and 238 visiting consultants, in addition to nursing and paramedical staff in hospitals. Each of its hospitals operates under an autonomous team of professionals with a Chief Operating Officer as head.

Gujarat is a structurally under-penetrated healthcare market with a population of ~7.04 crore in 2023, projected to reach 9 crore by 2030, while the state has only ~64,862 hospital beds against an estimated requirement of 352,000 beds, implying a shortfall of 287,000 beds. Additionally, chronic kidney disease (CKD) cases are increasing nationally, with India contributing nearly one-third of global CKD cases and 210,000 new kidney failure cases diagnosed annually. Although Gujarat has 272 operating dialysis centres and almost 1,281 dialysis machines, specialised kidney treatment and transplantation facilities are available in a very short network of centres, leaving room for organised players. Therefore, the company is poised to benefit with a focus on central Gujarat, expertise in renal sciences, urology, and cardiology, presence in Tier II/III cities with untapped demand, and an asset-light acquisition strategy, which is in sync with the growing demand for healthcare in the state.

The company aims to pursue strategic inorganic growth opportunities, implement initiatives to improve existing operational efficiencies, continue to recruit and retain skilled healthcare professionals and strengthen its existing hospitals and add new capabilities and specialities.

Now, Gujarat Kidney and Super Speciality Ltd is launching its initial public offering (IPO), which consists of a fresh issue of ₹250.80 crore. The total issue size of the IPO is ₹250.80 crore. Its shares will be listed on the NSE and BSE.

How to pre-apply for the Gujarat Kidney & Super Speciality IPO?

You can pre-apply for the Gujarat Kidney & Super Speciality IPO on Upstox. The pre-application for this IPO, which means the pre-apply open date, usually begins a day before the IPO opens for subscription.

Follow these steps to pre-apply for the IPO:

Login to your Upstox account, using your six-digit PIN
After successfully logging in, click on ‘Discover’
On the Discover tab, you will find the ‘Invest in IPO’ section
Under the Invest in IPO section, look for the ‘Gujarat Kidney & Super Speciality IPO’ tab and click on it
Now fill in all the required information, like ‘bid price’ and ‘lot size’
Confirm and click on ‘Pre-Apply’
Accept the mandate on your UPI app

How to apply for the Gujarat Kidney & Super Speciality IPO?

If you are interested in this investment opportunity but unsure how to apply for the Gujarat Kidney & Super Speciality IPO, here are the steps that you need to follow.

When the public issue opens for subscription, one can follow this step-by-step guide on how to apply for the Gujarat Kidney & Super Speciality IPO on Upstox:

Log in to your Upstox account, using your six-digit PIN
After logging in, click on ‘Discover’
On the ‘Discover’ tab, you will find the ‘Invest in IPO’ section
Under the Invest in IPO section, look for the ‘Gujarat Kidney & Super Speciality IPO’ tab and click on it
Now fill in all the required information, like ‘bid price’ and ‘lot size’
Confirm and click on ‘Apply’
Accept the mandate on your UPI app

How to check Gujarat Kidney & Super Speciality IPO Allotment Status?

When the allotment process is completed, you can check the status of your application on the Upstox app. Share allotment is generally completed on the next working day after an IPO closes.

Here’s a step-by-step guide on how to check the Gujarat Kidney & Super Speciality IPO allotment status:

Login to your Upstox account, using your six-digit PIN
After logging in, click on ‘Discover’
On the ‘Discover’ page, you will find the ‘Invest in IPO’ section
Under the Invest in IPO section, you will find the ‘View all’ option
Once you click on ‘View all’, you will be directed to the ‘IPO’ tab
In the ‘IPO’ tab, click on ‘My applications’
In ‘My applications’, under the History section, your Gujarat Kidney & Super Speciality IPO allotment status will be mentioned

IPO Analysis

IPO REVIEW

Gujarat Kidney & Super Speciality IPO | Analysis Video

Gujarat Kidney & Super Speciality IPO

Should you apply?

View Video